Danny A Asogun
Overview
Explore the profile of Danny A Asogun including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
707
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moore K, Ostrowsky J, Mehr A, Johnson R, Ulrich A, Moua N, et al.
Lancet Infect Dis
. 2024 Jul;
24(11):e696-e706.
PMID: 38964363
In 2016, WHO designated Lassa fever a priority disease for epidemic preparedness as part of the WHO Blueprint for Action to Prevent Epidemics. One aspect of preparedness is to promote...
2.
Kotliar D, Raju S, Tabrizi S, Odia I, Goba A, Momoh M, et al.
Nat Microbiol
. 2024 Feb;
9(3):751-762.
PMID: 38326571
Infection with Lassa virus (LASV) can cause Lassa fever, a haemorrhagic illness with an estimated fatality rate of 29.7%, but causes no or mild symptoms in many individuals. Here, to...
3.
Erameh C, Koch T, Edeawe O, Oestereich L, Omansen T, Jochum J, et al.
J Infect
. 2023 Apr;
87(1):27-33.
PMID: 37075910
Background: Managing Lassa fever (LF) patients is challenging because of the complexity of this life-threatening infectious disease, the necessary isolation measures, and the limited resources in countries where it is...
4.
Okogbenin E, Seb-Akahomen O, Edeawe O, Ehimigbai M, Eboreime H, Odike A, et al.
BMJ Open
. 2022 May;
12(5):e058561.
PMID: 35523500
Objective: To estimate the prevalence of depression and anxiety and identify associated risk factors in hospitalised persons with confirmed COVID-19 in Edo, Nigeria. Design: A multicentre cross-sectional survey. Setting: Patients...
5.
Botti-Lodovico Y, Nair P, Nosamiefan D, Stremlau M, Schaffner S, Agignoae S, et al.
Viruses
. 2021 Aug;
13(8).
PMID: 34452470
While investigating a signal of adaptive evolution in humans at the gene LARGE, we encountered an intriguing finding by Dr. Stefan Kunz that the gene plays a critical role in...
6.
Strampe J, Asogun D, Speranza E, Pahlmann M, Soucy A, Bockholt S, et al.
Lancet Infect Dis
. 2021 Jan;
21(6):876-886.
PMID: 33484646
Background: Lassa fever is endemic in several west African countries. Case-fatality rates ranging from 21% to 69% have been reported. The pathophysiology of the disease in humans and determinants of...
7.
Adetunji A, Ayenale M, Akhigbe I, Akerele L, Isibor E, Idialu J, et al.
Int J Infect Dis
. 2020 Nov;
103:124-131.
PMID: 33176203
Objectives: To assess the prevalence of acute kidney injury (AKI), and its impact on outcome in hospitalized pediatric patients with Lassa fever (LF). Methods: We reviewed the presenting clinical and...
8.
Boisen M, Uyigue E, Aiyepada J, Siddle K, Oestereich L, Nelson D, et al.
Sci Rep
. 2020 May;
10(1):8724.
PMID: 32457420
Lassa virus (LASV) is the causative agent of Lassa fever (LF), an often-fatal hemorrhagic disease. LF is endemic in Nigeria, Sierra Leone and other West African countries. Diagnosis of LASV...
9.
Asogun D, Gunther S, Akpede G, Ihekweazu C, Zumla A
Infect Dis Clin North Am
. 2019 Nov;
33(4):933-951.
PMID: 31668199
Lassa fever outbreaks West Africa have caused up to 10,000 deaths annually. Primary infection occurs from contact with Lassa virus-infected rodents and exposure to their excreta, blood, or meat. Incubation...
10.
Akpede G, Asogun D, Okogbenin S, Dawodu S, Momoh M, Dongo A, et al.
Front Public Health
. 2019 Sep;
7:251.
PMID: 31544101
[This corrects the article DOI: 10.3389/fpubh.2019.00170.].